Specify Company / Ticker to Get the Summary
Dividend History ALT
Dividend Analytics ALT
Max Ratio
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Altimmune Inc
ALTAltimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity, metabolic, and liver diseases. Its lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist, which is in Phase 3 trial for the treatment of obesity and metabolic associated steatohepatitis. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland. Address: 910 Clopper Road, Gaithersburg, MD, United States, 20878
Analytics
WallStreet Target Price
20.63 USDP/E Ratio
–Dividend Yield
–Financials ALT
Results | 2019 | Dynamics |